Rare diseases - still rare disease, but no longer orphans
13 Oct 2017
Historically, rare diseases were also called orphan diseases. They were orphans because no one was developing therapies for them. There was no chance that a company would be able to recover its investment if it spent time and money developing a treatment for such a small population. Some of these diseases are no longer ‘orphans’ in this regard, because the bio-pharmaceutical industry is now ‘adopting’ them slowly, but steadily. Nonetheless, rarity remains the defining feature of these diseases.
The annual Bega duck race in Timisoara, Romania, went off with a splash on Sunday 3rd September, as hundreds of rubber ducks took to the water and went beak-to-beak in some of the most intense racing ever seen across the river Bega.
Representing Cmed in the hotly contested “Sponsor Race” was Doctor Duck. Crowds cheered on as ten rubber ducks in a row bobbed down the river in the big race of the day, eagerly awaiting the winner with bated breath.
Can you say, “Welcome to the wide, wonderful world of wearables”, three times fast?
Disruptive Innovations landed in Boston last week, once again bringing together Innovation Teams and Market Disruptors to listen, learn and share how they are looking to leap forward in clinical trials.
Wearables continued to be a topic of discussion throughout the two day conference. Whereas in the past, wearables were introduced as a possibility, this year established sponsors were showing off successful proof of concepts and new tech vendors were bringing in gadgets that went well beyond using a Fitbit to track steps.